Health Care & Life Sciences » Biotechnology | Naturalendo Tech Co. Ltd.

Naturalendo Tech Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
84,281
124,067
44,506
6,556
9,239
Cost of Goods Sold (COGS) incl. D&A
24,408
40,056
14,682
4,788
6,396
Gross Income
59,873
84,012
29,824
1,768
2,843
SG&A Expense
35,706
58,125
40,715
10,851
8,234
EBIT
24,104
25,887
10,910
11,210
5,391
Unusual Expense
-
-
763
707
64
Non Operating Income/Expense
262
526
7,872
873
903
Interest Expense
-
6
14
271
2,754
Pretax Income
24,354
26,124
19,393
12,991
7,486
Income Tax
5,074
5,363
3,839
356
1,375
Equity in Affiliates
-
-
90
542
-
Consolidated Net Income
19,280
20,761
15,645
13,177
8,861
Net Income
19,280
20,761
15,516
13,177
8,861
Net Income After Extraordinaries
19,280
20,761
15,516
13,177
8,861
Net Income Available to Common
19,280
20,761
15,516
13,177
8,861
EPS (Basic)
1,143.33
1,081.00
803.00
683.00
455.00
Basic Shares Outstanding
17
19
19
19
19
EPS (Diluted)
1,045.35
1,057.53
803.06
682.94
454.70
Diluted Shares Outstanding
19
20
19
19
19
EBITDA
24,198
26,658
9,477
9,741
3,897
Other Operating Expense
64
-
20
2,127
-
Non-Operating Interest Income
512
770
166
71
488
Minority Interest Expense
-
-
128
-
-
Equity in Affiliates (Pretax)
-
-
-
-
796

About Naturalendo Tech Co.

View Profile
Address
3/F, Building A CS Tower
Seongnam GY 13486
Korea, Republic Of
Employees -
Website http://www.naturalendo.co.kr
Updated 09/14/2018
Naturalendo Tech Co., Ltd. engages in the physical, chemical, biological research and development of healthcare materials. The company engages in following business activities which include the research, development, manufacture and sale of health food materials, cosmetic materials and drug delivery system. It also offers hormone replacement therapy and non-hormone therapy for women.